These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 38642225)

  • 21. Environmental triggers of Parkinson's disease - Implications of the Braak and dual-hit hypotheses.
    Chen H; Wang K; Scheperjans F; Killinger B
    Neurobiol Dis; 2022 Feb; 163():105601. PubMed ID: 34954321
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advancements in Genetic and Biochemical Insights: Unraveling the Etiopathogenesis of Neurodegeneration in Parkinson's Disease.
    Ratan Y; Rajput A; Pareek A; Pareek A; Jain V; Sonia S; Farooqui Z; Kaur R; Singh G
    Biomolecules; 2024 Jan; 14(1):. PubMed ID: 38254673
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Underrepresented Populations in Parkinson's Genetics Research: Current Landscape and Future Directions.
    Schumacher-Schuh AF; Bieger A; Okunoye O; Mok KY; Lim SY; Bardien S; Ahmad-Annuar A; Santos-Lobato BL; Strelow MZ; Salama M; Rao SC; Zewde YZ; Dindayal S; Azar J; Prashanth LK; Rajan R; Noyce AJ; Okubadejo N; Rizig M; Lesage S; Mata IF;
    Mov Disord; 2022 Aug; 37(8):1593-1604. PubMed ID: 35867623
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Awareness and current knowledge of Parkinson's disease: a neurodegenerative disorder.
    Khan AU; Akram M; Daniyal M; Zainab R
    Int J Neurosci; 2019 Jan; 129(1):55-93. PubMed ID: 29883227
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidemiology of Parkinson's disease.
    Tysnes OB; Storstein A
    J Neural Transm (Vienna); 2017 Aug; 124(8):901-905. PubMed ID: 28150045
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative features of the epidemiology of multiple sclerosis and Parkinson's disease: environmental factors of potential etiological importance.
    Ubeda JV
    J Neurol Sci; 2007 Nov; 262(1-2):54-9. PubMed ID: 17663005
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advances in environmental epidemiology.
    Tanner CM
    Mov Disord; 2010; 25 Suppl 1():S58-62. PubMed ID: 20187243
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Update in the epidemiology of Parkinson's disease.
    Elbaz A; Moisan F
    Curr Opin Neurol; 2008 Aug; 21(4):454-60. PubMed ID: 18607207
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Leucine-Rich Repeat Kinase (LRRK2) Genetics and Parkinson's Disease.
    Monfrini E; Di Fonzo A
    Adv Neurobiol; 2017; 14():3-30. PubMed ID: 28353276
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidemiology of Parkinson's disease.
    de Lau LM; Breteler MM
    Lancet Neurol; 2006 Jun; 5(6):525-35. PubMed ID: 16713924
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neurodegenerative Disorders and the Current State, Pathophysiology, and Management of Parkinson's Disease.
    Rahul ; Siddique Y
    CNS Neurol Disord Drug Targets; 2022; 21(7):574-595. PubMed ID: 34477534
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetics of Parkinson's disease.
    Lill CM
    Mol Cell Probes; 2016 Dec; 30(6):386-396. PubMed ID: 27818248
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disturbances of Sleep and Alertness in Parkinson's Disease.
    Videnovic A
    Curr Neurol Neurosci Rep; 2018 Apr; 18(6):29. PubMed ID: 29675716
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Changing Landscape of Parkinson Epidemiologic Research.
    Chen H
    J Parkinsons Dis; 2018; 8(1):1-12. PubMed ID: 29154293
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Research on the premotor symptoms of Parkinson's disease: clinical and etiological implications.
    Chen H; Burton EA; Ross GW; Huang X; Savica R; Abbott RD; Ascherio A; Caviness JN; Gao X; Gray KA; Hong JS; Kamel F; Jennings D; Kirshner A; Lawler C; Liu R; Miller GW; Nussbaum R; Peddada SD; Rick AC; Ritz B; Siderowf AD; Tanner CM; Tröster AI; Zhang J
    Environ Health Perspect; 2013; 121(11-12):1245-52. PubMed ID: 23933572
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Depression in Parkinson's disease. Part 1: epidemiology, signs and symptoms, pathophysiology and diagnosis].
    Storch A; Ebersbach G; Fuchs G; Jost WH; Odin P; Reifschneider G; Bauer M
    Fortschr Neurol Psychiatr; 2008 Dec; 76(12):715-24. PubMed ID: 19012223
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidemiology of Parkinson's disease.
    Alves G; Forsaa EB; Pedersen KF; Dreetz Gjerstad M; Larsen JP
    J Neurol; 2008 Sep; 255 Suppl 5():18-32. PubMed ID: 18787879
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Understanding the links between cardiovascular disease and Parkinson's disease.
    Potashkin J; Huang X; Becker C; Chen H; Foltynie T; Marras C
    Mov Disord; 2020 Jan; 35(1):55-74. PubMed ID: 31483535
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epidemiology of Parkinson's disease.
    Tanner CM; Goldman SM
    Neurol Clin; 1996 May; 14(2):317-35. PubMed ID: 8827174
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autonomic dysfunction in Parkinson's disease: Implications for pathophysiology, diagnosis, and treatment.
    Chen Z; Li G; Liu J
    Neurobiol Dis; 2020 Feb; 134():104700. PubMed ID: 31809788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.